Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SHBG | P04278 | 1/20 | 0.38 |
| ▸ | TP53 | P04637 | 1/20 | 0.35 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.34 |
| ▸ | GMNN | O75496 | 1/20 | 0.34 |
| ▸ | LMNA | P02545 | 1/20 | 0.34 |
| ▸ | MAPT | P10636 | 1/20 | 0.34 |
| ▸ | BLM | P54132 | 1/20 | 0.34 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.34 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.34 |
| ▸ | EPHX1 | P07099 | 3/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | CA12 | O43570 | 2/20 | 0.32 |
| ▸ | CA1 | P00915 | 2/20 | 0.32 |
| ▸ | CA2 | P00918 | 2/20 | 0.32 |
| ▸ | MMP2 | P08253 | 2/20 | 0.32 |
| ▸ | CA9 | Q16790 | 2/20 | 0.32 |
| ▸ | PDK1 | Q15118 | 1/20 | 0.32 |
| ▸ | PDK2 | Q15119 | 1/20 | 0.32 |
| ▸ | PDK3 | Q15120 | 1/20 | 0.32 |
| ▸ | PDK4 | Q16654 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10285051 | 0.89 | ALDH1A1 (0.30) | SHBGALDH1A1 | |
| SCHEMBL23082595 | 0.83 | SHBG (0.38) | SHBGTP53KDM4EGMNNLMNA | |
| SCHEMBL16448766 | 0.81 | SHBG (0.46) | SHBGTP53KDM4EGMNNLMNA | |
| SCHEMBL11981328 | 0.78 | TP53 (0.50) | SHBGTP53KDM4EGMNNLMNA | |
| SCHEMBL13856028 | 0.78 | PDK1 (0.36) | SHBGTP53KDM4EGMNNLMNA | |
| SCHEMBL10215033 | 0.78 | PDK1 (0.36) | SHBGTP53KDM4EGMNNLMNA | |
| SCHEMBL14113521 | 0.78 | TP53 (0.36) | SHBGTP53KDM4EGMNNLMNA | |
| SCHEMBL10170762 | 0.78 | PDK1 (0.36) | SHBGTP53KDM4EGMNNLMNA | |
| SCHEMBL2997255 | 0.77 | SHBG (0.37) | SHBGTP53KDM4EGMNNLMNA | |
| SCHEMBL746973 | 0.77 | SHBG (0.37) | SHBGTP53LMNASMN1; SMN2EPHX1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 41 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2755938-B1 | METHOD FOR PRODUCING 4-CYCLOHEXYL-2-METHYL-2-BUTANOL | BASF SE (DE) | 2017-03-01 | — | — | EP | claimed |
| CN-106187685-A | The method preparing 4 cyclohexyl 2 methyl 2 butanol | 巴斯夫欧洲公司 | 2016-12-07 | — | — | CN | claimed |
| US-20160311741-A1 | PROCESS FOR PREPARING 4-CYCLOHEXYL-2-METHYL-2-BUTANOL | BASF SE (DE) | 2016-10-27 | — | — | US | claimed |
| CN-105967975-A | Process for the preparation of 4-cyclohexyl-2-methyl-2-butanol | 巴斯夫欧洲公司 | 2016-09-28 | — | — | CN | claimed |
| US-20150246864-A1 | PROCESS FOR PREPARING 4-CYCLOHEXYL-2-METHYL-2-BUTANOL | BASF SE (DE) | 2015-09-03 | — | — | US | claimed |
| US-20150225325-A1 | PROCESS FOR PREPARING 4-CYCLOHEXYL-2-METHYL-2-BUTANOL | BASF SE (DE) | 2015-08-13 | — | — | US | claimed |
| EP-2755938-A1 | METHOD FOR PRODUCING 4-CYCLOHEXYL-2-METHYL-2-BUTANOL | BASF SE (DE) | 2014-07-23 | — | — | EP | claimed |
| CN-103796980-A | Process for preparing 4-cyclohexyl-2-methyl-2-butanol | BASF SE | 2014-05-14 | — | — | CN | claimed |
| EP-2550248-B1 | PROCESS FOR THE PREPARATION OF 4-CYCLOHEXYL-2-METHYL-2-BUTANOL | BASF SE (DE) | 2014-03-19 | — | — | EP | claimed |
| US-20130245132-A1 | PROCESS FOR PREPARING 4-CYCLOHEXYL-2-METHYL-2-BUTANOL | BASF SE (DE) | 2013-09-19 | — | — | US | claimed |
| WO-2013037737-A1 | METHOD FOR PRODUCING 4-CYCLOHEXYL-2-METHYL-2-BUTANOL | BASF SE (DE) | 2013-03-21 | — | — | WO | claimed |
| US-20130072726-A1 | PROCESS FOR PREPARING 4-CYCLOHEXYL-2-METHYL-2-BUTANOL | BASF SE (DE) | 2013-03-21 | — | — | US | claimed |
| EP-2550248-A2 | PROCESS FOR THE PREPARATION OF 4-CYCLOHEXYL-2-METHYL-2-BUTANOL | BASF SE (DE) | 2013-01-30 | — | — | EP | claimed |
| CN-102822130-A | Process for preparing 4-cyclohexyl-2-methyl-2-butanol | BASF SE | 2012-12-12 | — | — | CN | claimed |
| WO-2011117360-A2 | PROCESS FOR THE PREPARATION OF 4-CYCLOHEXYL-2-METHYL-2-BUTANOL | BASF SE (DE) | 2011-09-29 | — | — | WO | claimed |
| US-20110237684-A1 | Process for preparing 4-cyclohexyl-2-methyl-2-butanol | BASF SE (DE) | 2011-09-29 | — | — | US | claimed |
| EP-2722323-B1 | Process for the preparation of 2-methyl-4-phenyl-2-pentanol | BASF SE (DE) | 2018-11-28 | — | — | EP | disclosed |
| EP-2755938-B1 | METHOD FOR PRODUCING 4-CYCLOHEXYL-2-METHYL-2-BUTANOL | BASF SE (DE) | 2017-03-01 | — | — | EP | disclosed |
| WO-2011117360-A2 | PROCESS FOR THE PREPARATION OF 4-CYCLOHEXYL-2-METHYL-2-BUTANOL | BASF SE (DE) | 2011-09-29 | — | — | WO | disclosed |
| US-20110237684-A1 | Process for preparing 4-cyclohexyl-2-methyl-2-butanol | BASF SE (DE) | 2011-09-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150225325-A1 | PROCESS FOR PREPARING 4-CYCLOHEXYL-2-METHYL-2-BUTANOL | CYP4B1, HPD, ADH1C | SHBG 4537/4885TP53 2402/4885KDM4E 74/4885 |
| US-20110237684-A1 | Process for preparing 4-cyclohexyl-2-methyl-2-butanol | CYP4B1, HPD, ADH1C | SHBG 4537/4885TP53 2402/4885KDM4E 74/4885 |
| US-20160311741-A1 | PROCESS FOR PREPARING 4-CYCLOHEXYL-2-METHYL-2-BUTANOL | ADH1C, CYP4B1, ADH1A | SHBG 4338/4885TP53 2253/4885KDM4E 135/4885 |
| US-20130072726-A1 | PROCESS FOR PREPARING 4-CYCLOHEXYL-2-METHYL-2-BUTANOL | ADH1C, CYP4B1, ADH1A | SHBG 4338/4885TP53 2253/4885KDM4E 135/4885 |
| US-20150246864-A1 | PROCESS FOR PREPARING 4-CYCLOHEXYL-2-METHYL-2-BUTANOL | ADH1C, CYP4B1, ADH1A | SHBG 4338/4885TP53 2253/4885KDM4E 135/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.